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Abstract: In the processes related to the development of cancer, there are different genetic and
epigenetic events involved that result in structural changes of the affected cells. In the early stages
of the disease, these changes occur at the nanoscale, remaining undetectable by conventional
light microscopy, due to diffraction-limited resolution (∼250 - 550 nm). In this sense, a technique
termed partial wave spectroscopy (PWS) allows the detection of these nanostructural changes
by measuring a statistical parameter called disorder strength (Ld). PWS uses a combination of
a tunable filter and a camera to acquire the backscattering spectra for each pixel on the image.
In this paper, we study and validate the possibility of obtaining a qualitative measurement of
the disorder using the spectrum of the averaged spatial information. Instead of using spatial
information and measuring sequentially spectral ranges, we measure the backscattered signal
gathered by an optical fiber by means of a spectrograph. This will allow this method to be applied
in systems where it is not possible to acquire a complete high resolution image for many spectral
bands, while significantly enhancing speed.
© 2020 Optical Society of America under the terms of the OSA Open Access Publishing Agreement
1. Introduction
Although it can not be observed through conventional microscopy, healthy tissue suffers from
different alterations before the development of a tumor, the so-called field cancerization [1]. The
term refers to the presence of transformed cell primary tumors or abnormal tissue surrounding
the cancerous region. It is related to the disease progression and relapse, involving multiple
molecular events prior to tumor initiation and migration. This effect has been observed in nearly
all kind of tissues present in the different organ systems of the human body [2]. A method able
to detect these nanoscale changes, before the development of a tumor, is paramount in order
to prevent and prematurely treat diseases in which the reaction time is a main factor [3]. In
developed stages it has also a prime importance, helping to monitor tumor progression and
defining tumor margins [4].
In this sense, electron microscopy (EM) has been studied for years as a support technique for
light microscopy in tumor diagnosis [5,6]. Despite the fact that this technique allows the study of
the structural features of the cell at nanoscale [7–9], it has important drawbacks. Among these
drawbacks are the elevated cost of the instrument and its size, the regular power consumption, high
degree of maintenance, researcher training and image artifacts resulting from sample preparation
[10,11]. In light of this scenario, it is necessary to count on a more functional and versatile
system to evaluate the nanostructure of cell, even in vivo, with minimum tissue preparation. Thus,
a technique known as partial wave spectroscopy (PWS), introduced by V. Backman et al., has
been recently developed and validated [12–19].
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PWS is based on the idea that the backscattering spectrum of a weakly disordered medium
contains spectral fluctuations that can be used to quantify the disorder strength based on the
refractive index fluctuations within the cell, n. At a given location within the cell, n is proportional
to the local density of macromolecules with refraction increment, ∆n, practically independent of
chemical composition. Thus, the spatial variations of macromolecular density can be measured
once the fluctuations of n are known, assuming these fluctuations are random and within a
correlation distance lc.
The acquired spectrum of backscattered light is the result of the interference between the
scattering produced by all n variations within an intracellular volume and the reflection from the
interface at the surface of the cell. The measured spectra is therefore formed by a subset of the
scattered waves, considering each pixel in an image a 1D weakly disordered medium.
In this 1D weakly disordered medium, of length L, the probability density distribution of the
reflectance fluctuations, R, follows a log-normal distribution (i.e. ln(R) is a Gaussian function)
for all length scales of this scattering medium.
Making use of the expected distribution for the reflection fluctuation, 〈R〉, and applying
mesoscopic light transport theory [20], an expression for the disorder strength, Ld, is obtained
from the correlation of these fluctuations, 〈C(∆k)〉, for the wavenumber k = 2pi/λ [13,14].
Ld ' −β 〈R〉k2c
(∆k)2
ln〈C(∆k)〉 (1)
where β is a calibration constant determined experimentally [14], and the value for kc is chosen
as the central wavenumber of the measured spectra, kc = 2pi/〈λ〉. Finally, (∆k)2/ln〈C(∆k)〉 is
found by performing a linear fit of ln〈C(∆k)〉 vs (∆k)2.
PWS method was initially applied by spatially scanning the slit of a spectrograph and imaging
the slit into a CCD camera to acquire each pixel’s 1D backscattering information. The data
collection using this method took around 4 - 5 minutes for a field of view which includes a
single cell [13,14]. In subsequent works, the acquisition was done by the combination of a liquid
crystal filter and a CCD camera. Thus, the backscattered image of the cell is collected for a
range between 400 - 700 nm, avoiding the need of point scanning the sample. This results in
a faster acquisition rate, 4 - 5 s for a single field of view [21]. Despite of this and due to their
characteristics, these approaches are not suitable to be implemented in systems where the space
and conditions are restricted, such as in small fiber endoscopy. In this sense, we evaluate the
possibility of using a setup based on an spectrometer to calculate the Ld parameter directly from
the backscattering signal gathered by an optical fiber.
2. Methods
2.1. Theoretical model
The PWS technique [13–15] was followed to measure spectral fluctuations in the backscattering
spectra to obtain the statistical parameter termed disorder strength (Ld). This technique expresses
a 3D disordered medium as various parallel and spatially independent 1D channels, acquiring
the 1D reflection spectra fluctuation, R(k), where k is formed by the interference of light waves
propagating in these 1D channels and back-reflecting. For each pixel (x, y), it is therefore obtained
∆n2 as the variance of refractive index fluctuations of ∆n. In this way, a 2D map of the disorder
strength, Ld(x, y), can be constructed, showing the spatial distribution of the disorder in the image
under analysis. R(k) is computed from the intensity vs wavelength measurement, I(k), for each
pixel in an image. To obtain R(k), the signal I(k) is filtered out by using a low-pass Butterworth
filter to remove high-frequency noise. The variations in the lamp spectrum, sample roughness
and instrument artifacts are also filtered by fitting a low order polynomial, Ip(k), to I(k). The
fluctuating part of the reflection coefficient, R(k), is obtained as R(k) = I(k) − Ip(k).
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We here include the derivation found in Refs. [13,14] in order to provide a more complete
description of the method. In a scattering medium with low disorder (R  1), the probability
density distribution of R follows a log-normal distribution for all length scales. The ensemble
average of the R distribution over the ensemble of 1D independent parallel disordered channels











where n0 represents the average refractive index of the medium, and L is the dimension along
the direction of incident light propagation through the medium. It is assumed in Eq. (2) that



























By using the auto-correlation function 〈C(∆k)〉:
〈C(∆k)〉 = 〈R(k)R(k + ∆k)〉〈R(k)R(k)〉 , (6)






where α is a constant, with units of length, and f (Ld) is a slowly varying function of Ld, which
may be considered constant for the ranges of k taken into account. Using Eq. (7) and Eq. (3), the
length L of the 1D system, which is unknown experimentally and directly related to the temporal
coherence length of the source, is removed from the equation:












αf (Ld)(∆k)2 . (9)






By grouping constants (and slowly varying functions), we obtain [14]:
Ld ' −β 〈R〉k2
(∆k)2
ln〈C(∆k)〉 (11)
where β is a calibration constant determined experimentally. Equation (11) has a 1/k2 dependence
and (∆k)2/ln〈C(∆k)〉 is found by performing a linear fit of ln〈C(∆k)〉 vs (∆k)2.
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In order to evaluate the application of Ld calculation method to the whole spectrum measured by a
spectrometer, a dual setup, depicted in Fig. 1, was used. This setup allowed us to simultaneously
perform measurements of the backscattering spectra using the two methods mentioned in the
introduction section.
Fig. 1. Dual acquisition setup schematic.
2.2.1. Image based measurements
The first of these methods was implemented by using a combination of a Thorlabs Kurios WB1
tunable filter and a Thorlabs DCC1545M CCD camera to collect the backscattered light coming
from a regular epi-fluorescence microscope, modified to acquire backreflected images from the
sample. Through a internal beamsplitter, the light coming from a Hg lamp was guided to the
sample (Fig. 2) . After illuminating the sample, the backscattering light passed again through
the beamsplitter and it was directed to the CCD camera through the tunable filter. Thanks to
the use of the tunable filter, it is possible to collect the backscattering intensity of a particular
wavelength into the CCD camera without the need of perform a scan of the image pixel by pixel
[21]. The range of the center wavelengths of tunable filter goes from 420 nm to 730 nm. Despite
of this, the scan was performed from 500 nm to 650 nm to avoid being affected by noise due to
low quantum efficiency wavelengths on CCD camera. The PWS technique was then followed to
measure spectral fluctuations in the backscattering spectra to obtain the Ld parameter.
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Fig. 2. Image based measurements setup, showing the light path followed by the Hg
illumination to the sample and the path followed by the backscattering signal to the CCD
camera.
2.2.2. Fiber based measurements
The second measuring method, through an optical fiber, is shown in Fig. 3. It was implemented
to work simultaneously with the image based measurements, making use of a beamsplitter
attached to the microscope output. The optical fiber was used to direct the backscattering light,
collected by a fiber collimator, to a Hamamatsu C13555MA mini-spectrometer to measure the
full spectrum of the backscattered light. In order to apply the PWS theory, the mean reflectance
used to extract Ld parameter was calculated for a single mean intensity value for each wavelength
instead of calculating it for each pixel. Thus, we have termed this disorder parameter as Ld, which
is a single-valued disorder parameter representing the mean disorder strength of the sample.
Although it is not possible to construct a 2D map of the disorder strength, a qualitative parameter
representing the mean disorder of the sample is obtained. To extract this parameter, the equations
developed above (Eqs. (2) to (13)) were applied. This qualitative information, proportional to size
and density of macromolecular architecture, allowed the separation of different tissue samples
and different areas of the same tissue.
Fig. 3. Fiber based measurements setup. The light path and common parts have been
intentionally omitted to shown in isolation the fiber based measurement module.
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3. Results and discussion
Different samples of thicknesses varying between 4 and 6 µm were measured using both methods
simultaneously to compare the results and evaluate the similarities obtained. The samples
used were histological sections of several healthy human tissue types, prepared with routine
histological staining. A set of these samples is shown in Fig. 4. Using the setup described in
Fig. 1, different areas of the same microscope slide containing the sample were measured. To
determine the area seen by the fiber between each set of measurements, a laser beam was guided
from the side of the spectrometer to the sample. Thus, the illuminated area showed the zone to be
measured by the spectrometer. This area was a ∼0.7 mm diameter circumference, as it is shown
in Fig. 5. Then, the disorder parameter (Ld or Ld) was obtained for each case using the methods
already discussed. Since a 50:50 beamsplitter was employed, the intensity of the backscattered
signal was halved. Despite of this, the illumination source provided good SNR in both the CCD
camera and the spectrometer.
Fig. 4. Histological samples used for measurement’s evaluation: a) Human skin (sample
1), b) Human skin (sample 2), c) Small intestine, d) Cardiac muscle. These images were
obtained using an inverted microscope.
Fig. 5. Laser beam illuminating the area to be measured by the spectrometer. A circular
zone of 0.7 mm diameter is measured using this method.
As mentioned above, each sample was divided in three zones (Zone A, Zone B, Zone C), each
covering different regions of sample, as it is shown in Fig. 6 for a human skin sample. Then, the
Ld and Ld, obtained by each configuration respectively, were compared. In Fig. 7, the reflection
coefficient R(λ) extraction procedure is depicted for both measurement methods. Disorder then
is calculated from 〈C(∆k)〉 and 〈R〉 parameters. As it is shown in Fig. 8, 〈C(∆k)〉 has a (∆k2)
dependence.
Fig. 6. Detail of the three measured zones in each sample. The images shown corresponds
to Human skin (sample 1).
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Fig. 7. Graphical example of reflection coefficient R(λ) extraction for human skin sample
using the image based measurement method (a); and the fiber based measurement method (b).
In (a), the backscattering spectrum I(λ) of three different pixels is shown. In the following
steps, Ip(λ) is shown in red over the backscattering spectrum for one pixel (a) and for the
intensity gathered by the fiber (b) and then, the reflection coefficient R(λ) obtained in each
case after removing the noise of the signals. Background reflection was previously removed
in a) and b).
Fig. 8. The correlation decay showing the linear dependence of 〈C(∆k)〉 on (∆k2).
Measurements of Human Skin sample using a) image based method; b) fiber based method.
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Figure 9 shows the comparison between Ld and Ld parameters extracted from this human skin
sample (sample 1) and the standard deviation of the disorders (σ(Ld) and σ(Ld)) and the standard
errors of each measurement, represented as a black line over each bar. The standard deviation
follow similar variation than the disorder strength, as in [13,14].
Fig. 9. Comparison of a) human skin sample’s disorder obtained following PWS based on
a CCD + tunable filter system (gray color) and using the mean value of each wavelength
obtained by the spectrometer through the fiber (blue color); b) the standard deviation of Ld
and Ld for each measurement method, respectively. Error bars are depicted in black over
each measurement.
In the case of the image based method, the depicted Ld is the mean Ld for each zone. The
standard error shown was also the one obtained for this mean disorder value. It can be seen how
the values obtained through the fiber based method (Ld) concur with the ones obtained through
the image based method (Ld), showing the ability of the first to separate areas of the same sample
with different disorder, which is lower for zones with less tissue presence and vice versa. The
standard error obtained is slightly higher for fiber based measurements but it only represents
around the 3% of the value of Ld obtained for Zones B and C. For Zone A, the error is higher in
both methods, around 10%, but even in this case the error is sufficiently low to obtain qualitative
differences between this zone and the other zones. Also, it is noticeable how the disorder value
extracted from each zone is similar in both methods. The disorder obtained for each method and
zone are detailed in Table 1.
Table 1. Disorder strength and standard error for both measurement methods
Measurement Method Image based (µm · 10−3) Fiber based (µm · 10−3)
Zone Ld Error Ld Error
Zone A 0.32813 0.02610 0.31891 0.03340
Zone B 0.45525 0.00732 0.46713 0.01406
Zone C 0.64194 0.01124 0.67471 0.02454
To evaluate the consistence of the proposed method obtaining Ld parameter, the measurement
of zones with different sample presence was done for multiple samples. The samples and zones
analyzed are shown in Fig. 10. As in the aforementioned measurements, for each sample, three
different zones were measured (zones A, B and C). The same criteria was followed in all the
different samples with respect to the areas measured: Zone A covered a small amount of sample,
zone B covered medium amount of sample and zone C, a big amount of sample. The rest of the
area measured was empty microscope slide.
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Fig. 10. Set of different tissue samples used, showing the areas measured: a) Human skin
(sample 2), b) Cardiac muscle, c) Small intestine.
Fig. 11 shows the Ld calculated for these tissue samples following fiber based method. The
results show how the method is able to separate the different areas of the samples attending to
the different disorder of each zone. It is also capable of classifying the different healthy tissues
regarding to their Ld parameter. The small intestine sample showed the lower values of disorder
strength, followed by cardiac muscle sample.This is probably related to the higher heterogeneity
of the selected skin samples when compared to the other two, which presents more homogeneous
structures. In Table 2, Ld values obtained for each sample and zone are specified. Although the
qualitative values obtained by the proposed method cannot be numerically compared to the ones
obtained by original PWS method, the results were in accordance for different areas of the same
sample.
Fig. 11. Ld of three different samples obtained for three different zones of the microscope
slide containing the sample, following fiber based method. a) Human skin (sample 2); b)
Small intestine; c) Cardiac muscle.
Research Article Vol. 11, No. 10 / 1 October 2020 /Biomedical Optics Express 6047
Table 2. Ld obtained for three zones in three different tissue samples (shown in Fig. 10): a) Human
skin (sample 2) ; b) Cardiac muscle; c) Small intestine
Sample Ld (µm · 10−3) and standard error (µm · 10−3)
Zone a) Error b) Error c) Error
Zone A 0.25071 0.00929 0.12146 0.01574 0.08852 0.00601
Zone B 0.41923 0.00888 0.20272 0.00656 0.17667 0.00691
Zone C 0.57150 0.01474 0.39851 0.01464 0.43651 0.02914
4. Conclusion
An alternative method of applying the PWS technique by means of fiber-based measurements
has been validated. This technique makes use of an optical fiber to guide the backscattered light
from a sample to a spectrograph to analyze the whole spectrum and provides a spatially averaged
value proportional to the field’s of view present disorder. To validate the proposed method,
a dual acquisition setup was implemented in a modified epi-fluorescence microscope. This
setup allowed us to acquire the backscattering spectrum in a CCD camera and in a spectrometer,
through an optical fiber. That was done simultaneously to compare the disorder strength extracted
from the data measured by both methods in the same measurement conditions. For different
samples, this alternative method is also able to separate zones with different tissue presence. A
higher Ld value was obtained for areas located in the centre of the sample, where there was more
presence of the tissue and, therefore, higher disorder. This methodology offers the possibility
to compare the qualitative differences between samples and could be a potential useful tool to
discriminate between different stages of disease. However, due to the fact that it is not strictly
quantitative, it is not capable of providing a robust number that may be compared with other
modalities yielding values related to sample density or mean free path.
Further validation of this method is necessary to be carried out. In particular, it is needed to
evaluate its efficiency characterizing the same tissue in different stages of a particular disease,
such as tumors. Despite of this, the flexibility given by the optical fiber used to gather the light
together with the scanning speed and the results obtained in this first validation, opens up a way
of implementing this small footprint measurement method in systems with limited space and
restricted measurement conditions, such as endoscopes and other in-vivo detection systems.
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